Furthermore, we demonstrated that GAL1 overexpression induces epithelial-mesenchymal transition (EMT) in HepG2 HCC cells [27], a key process that contributes to cancer cell dissemination and confers drug resistance [28, 29]. This evidence concerns the gene LGALS1 and hepatocellular carcinoma.